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MG-132 reduces virus release in 
Bovine herpesvirus-1 infection
Filomena Fiorito1,2, Valentina Iovane3, Antonietta Cantiello2, Annarosaria Marullo  2,4, Luisa 
De Martino2 & Giuseppe Iovane2
Bovine herpesvirus 1 (BoHV-1) can provoke conjunctivitis, abortions and shipping fever. BoHV-1 
infection can also cause immunosuppression and increased susceptibility to secondary bacterial 
infections, leading to pneumonia and occasionally to death. Herein, we investigated the influence of 
MG-132, a proteasome inhibitor, on BoHV-1 infection in bovine kidney (MDBK) cells. Infection of MDBK 
cells with BoHV-1 induces apoptotic cell death that enhances virus release. Whereas, MG-132 inhibited 
virus-induced apoptosis and stimulated autophagy. Protein expression of viral infected cell protein 0 
(bICP0), which is constitutively expressed during infection and is able to stimulate Nuclear factor kappa 
B (NF-κB), was completely inhibited by MG-132. These results were accompanied by a significant delay 
in the NF-κB activation. Interestingly, the efficient virus release provoked by BoHV-1-induced apoptosis 
was significantly reduced by MG-132. Overall, this study suggests that MG-132, through the activation 
of autophagy, may limit BoHV-1 replication during productive infection, by providing an antiviral 
defense mechanism.
Bovine herpesvirus 1 (BoHV-1), a double-stranded DNA virus, is an important pathogen that in cattle can pro-
voke infectious bovine rhinotracheitis (IBR), conjunctivitis, abortions and shipping fever, which is a complicated 
infection of the upper respiratory tract. BoHV-1 initiates the disorder through immunosuppression that could 
render the animals more susceptible to secondary bacterial infections, leading to pneumonia and occasionally to 
death1,2. BoHV-1 establishes latency in sensory neurons of the infected host. Reactivation from latency is stimu-
lated by dexamethasone treatment or increases in natural corticosteroids resulting in virus shedding and spread 
to susceptible hosts1,2. The genes of BoHV-1, like other members of the alphaherpesvirus subfamily, are expressed 
in three temporally distinct phases identified as immediate-early (IE), early (E) and late (L) and it is generally 
approved that tissue-specific factors mediate pathogenesis and/or latency by influencing viral gene expression1. 
bICP0, the bovine homologue of herpes simplex virus type 1 (HSV-1) ICP0, regulates all three these phases by 
acting as a strong activator or as a repressor of specific viral promoters and is constitutively expressed during 
infection in permissive cells1,3,4. Thus, immediate-early bICP0 is considered to be the major regulatory protein 
that stimulates productive infection and inhibits interferon dependent transcription5. Infection of permissive cells 
(MDBK) with BoHV-1 leads to rapid cell death, partially due to apoptosis, which occurs during the late stages of 
infection by the activation of caspases, through modulation of Bcl-2 family members4,6–12. In the absence of viral 
gene expression, bICP0 indirectly induces caspase 3 activation and apoptosis13.
Found in almost all mammalian cell types, the transcription factor NF-κB regulates a wide range of genes 
important in development and prevention of apoptosis. Normally, NF-κB is sequestered within cytoplasm 
by virtue of its association with inhibitor IκBα. NF-κB can be released after that IκBα is phosphorylated and 
degraded, via the ubiquitin and proteasome pathway. As a result, the released NF-κB will be translocated into the 
nucleus, where it works as a transcriptional regulator of many related genes, playing critical role in inflammation, 
immunity, cell proliferation, differentiation, and survival14,15. Several viruses use cellular signaling pathways, like 
NF-κB, to stimulate viral gene expression16. Immediate early protein bICP0, could specifically stimulate NF-κB 
responsive reporter gene expression in different cell lines and induce NF-κB to translocate from cytoplasm into 
the nucleus where it promotes NF-κB DNA binding affinity17.
As above reported, viruses utilize various cellular signaling pathways during the course of their replication. 
The ubiquitin-proteasome system seems to be a cellular pathway that viruses use for their own benefit. Several 
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studies showed that proteasome inhibitors can alter virus replication by playing significant roles in replication 
cycle. For example, proteasome inhibitors decreased immediate early and late proteins expression in HSV-118, 
have a role in post-entry stages of HSV-1 infection19–24, and also facilitate the entry of HSV-1 at a post-penetration 
step25.
In this study, we used MG-132, a synthetic peptide inhibitor of the aldehyde proteasome pathway. Hence, 
MDBK cells, epithelial-like bovine cells commonly used for growing and assaying BoHV-1, were infected with 
BoHV-1 virus (Cooper strain), in the presence or absence of MG-132, and we examined the pathway of BoHV-
1-induced apoptosis, viral and cellular proteins, and analyzed virus replication in infected cells.
Results
MG-132 decreases cytotoxicity of MDBK during BoHV-1 infection. The effect of MG-132 on 
MDBK cell growth was determined by trypan blue exclusion test. We made a dose-response curve at different 
concentrations (1, 4, 10 and 20 μM). Dose-dependent inhibition of cell growth was observed in MDBK cells with 
an IC50 of approximately 10 μM MG132 for 24 h (Fig. 1A). MG-132 at 1 μM in MDBK cells induced no significant 
differences in cell viability (P > 0.5) (Figs. 1A, 6A). Moreover, MG-132 did not provoke the activation of caspases 
9 and 3 (Fig. 2A). Thus, we choose the concentration of MG-132 of 1 μM to use throughout the study.
In order to evaluate the effect of MG-132 on cell viability during BoHV-1 infection, MDBK cells were infected 
with BoHV-1 alone or in association with MG-132 (1 μM) and underwent, at different hours p.i., to Trypan Blue 
exclusion test, as described in Method section. A decrease in viability of BoHV-1 infected cells was observed in 
a time-dependent manner (Fig. 1B), as previously reported6,8,9,26,27. MG-132 induced a significant decrease in 
cytotoxicity of BoHV-1 infected cells (P < 0.05 and P < 0.01) (Fig. 1B).
MG-132 inhibits BoHV-1-induced apoptosis in MDBK cells. Analysis of BoHV-1 infected cells exhib-
ited activation of caspases 9 and 3, from 12 h after infection, as well as PARP cleavage (Fig. 2A). BoHV-1 induced 
phosphorylation of the key tumor suppressor p53 at serine 315 as later as 24 h to the end of infection (Fig. 2A), 
suggesting phosphorylation levels increased with cell death. Indeed, the infection caused a slight increase of p53 
protein levels. The levels of pro-apoptotic member Bax increased as a function of time after infection (Fig. 2), 
while decreased the levels of anti-apoptotic members such as Bcl-2 and Bcl-XL (Fig. 2).
Figure 1. MG-132 decreases cytotoxicity of MDBK during BoHV-1 infection. (A) MDBK cells were treated 
with MG-132 for 4, 24 or 48 h. (B) MDBK cells were infected with BoHV-1 alone or in association with MG-
132 for 4, 24 or 48 h. At different times of treatment cells were stained with Trypan-blue and scored with a 
Burker chamber at a light microscope. Data are presented as mean ± S.E.M. of three independent experiments 
performed in duplicate. Significant differences between infected untreated and infected MG-132-treated groups 
are indicated by probability P. *P < 0.05 and **P < 0.01.
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MG-132 completely inhibited BoHV-1-induced apoptosis, by blocking the activation of initiator caspase 9, 
as well as, of executioner caspase 3 (Fig. 2). In addition no cleavage of PARP was observed (Fig. 2). These results 
were accompanied by decrease of both pro-apoptotic and anti-apoptotic members (Fig. 2). From 12 h until the 
end of the infection, we observed a significant Bax/Bcl-2 ratio which was significantly diminished by MG-132 
(Fig. 2A,B) (P < 0.05 and P < 0.01). Our data showed that the levels of both p-p53 and p53 protein levels were 
decreased by MG-132 (Fig. 2A). Moreover, by measuring the p-p53/p53 ratio, we detected a significant decrease 
in MG-132 exposed groups, at all times studied (Fig. 2A–C) (P < 0.05 and P < 0.01).
Taken together, our results showed that MG-132 inhibited BoHV-1 induced apoptosis in MDBK cells.
MG-132 stimulates autophagy in MDBK cells during BoHV-1 infection. The influence of MG-132 
on autophagic markers was evaluated in MDBK cells during BoHV-1 infection at various times p.i. by Western 
Blot analysis. LC3 is a recognized marker for mammalian autophagocytosis28. LC3 protein is processed during 
autophagocytosis from an 18 kD protein (LC3-I) to a membrane bound 16 kD protein (LC3-II)28. As we showed 
in Fig. 3A,B, BoHV-1 infection in MDBK cells produced not significant levels of LC3-II. Whereas, MG-132 
induced in BoHV-1 infected groups a time-dependent increase in the amount of autophagy by increasing the 
conversion of the autophagy marker LC3 from LC3-I to LC3-II (Fig. 3A,B) and by enhancing the levels of ATG5, 
an additional autophagy-related protein markers and of Beclin 1, an autophagy related protein (Fig. 3A)28. In 
addition, we used another inducer of autophagy, like LiCl, which confirmed the activation of autophagy at 24 h 
p.i. (Fig. 3C). Whereas, 3-MA, an inhibitor of autophagy, at 24 h p.i., induced no significant differences in the level 
of LC3-II compared to infected control (Fig. 3C).
Furthermore, after Giemsa staining, as shown in Fig. 3D, at 48 h after infection, in MG-132 unexposed groups 
we detected an increase of intercellular spaces and some morphological alterations that indicated signs of both 
necrosis and apoptosis. Necrosis is morphologically characterized by swelling of organelles, plasma membrane 
rupture and subsequent loss of intracellular contents29, while apoptosis is accompanied by rounding-up of the 
cell, retraction of pseudopodes, chromatin condensation, nuclear fragmentation (karyorrhexis), plasma mem-
brane blebbing (but maintenance of its integrity until the final stages of the process)29. In MG-132 exposed groups 
a large number of cells exhibited an increase of characteristic signs of autophagy, such as an elevated degree 
of vacuolization in the cytoplasm (arrow) (Fig. 3D), which often indicates an increased autophagic flux28–30. 
Furthermore, detection of AVOs, as autophagic signs, was carried out by using lysosomotropic agent acridine 
orange (Fig. 3D). Autophagy is a process of sequestrating cytoplasmic proteins into the lytic component and to 
evaluate the AVOs in MG-132 treated cells, we performed the vital staining with acridine orange. At 48 h p.i., in 
acridine orange-stained cells, the cytoplasm and nucleolus fluoresced bright green and dim red, as resulted both 
in control and BoHV-1 groups (Fig. 3D), whereas, MG-132 enhanced acidic compartments which fluoresced in 
bright red (Fig. 3D). BHV-1 infected cells stained by acridine orange displayed both typical necrotic morphology 
(Fig. 3D - star) and apoptotic features (Fig. 3D - arrow). Whereas, we distinguished only necrotic features in few 
MG-132 infected cells (Fig. 3D - star).
In addition, after 48 h of infection, MG-132 increased punctate staining for LC3 compared to infected 
or uninfected controls, as detected by immunofluorescence for LC3, using epitope-specific antibody on 
paraformaldehyde-fixed cells (Fig. 3D). In particular, when MDBK cells were infected in the presence of MG-132, 
there was a strong accumulation of LC3-II (Fig. 3D). The amount of LC3 is correlated with the extent of autopha-
gosome formation28.
Our results displayed that during BoHV-1 infection MG-132 stimulated MDBK cells to undergo autophagy, 
in a time-dependent manner.
MG-132 inhibits protein expression of bICP0 during infection in MDBK cells. Following infec-
tion bICP0 has been regularly detected in infected cells since 2 h p.i. until the end of the infection (48 h) (Fig. 4), 
according to previous studies4,31. MG-132 completely inhibited protein expression of bICP0 during BoHV-1 
infection in MDBK cells (Fig. 4).
MG-132 delayed the translocation of NF-κB from cytoplasm to nuclei during infection in MDBK 
cells. Herein, to verify if MG-132 could determine changes in the NF-κB protein expression during BoHV-1 
infection, we measured NF-κB amount using Western blot assay. We detected NF-κB in cytosolic fraction during 
infection, and in nuclear fraction from 8 h to the end of infection (Fig. 5). The presence of MG-132 significantly 
delayed its translocation from cytoplasm to nuclei (Fig. 5), where NF-κB was detected in the last time of infection 
(Fig. 5).
Our results indicated that MG-132 influenced the activation of NF-κB, by delaying its translocation from 
cytoplasm to the nuclei.
MG-132 reduces virus production during productive infection in MDBK cells. To verify whether 
MG-132 exposure could affect the virus production, we analyzed both viral cytopathic effects and virus titration. 
To this aim MDBK cells were infected with BoHV-1 and exposed or not to MG-132 and processed as reported in 
Method Section.
The CPE, represented by ample syncytia formation along with elimination of the cellular sheet, was much 
evident in BoHV-1 unexposed after 48 h p.i. (Fig. 6) and particularly, in MG-132 treated groups it was possible 
appreciate an intense decrease of CPE (Fig. 6). To confirm that autophagy induction results in loss of BoHV-1 
infection, we used lithium, another inducer of autophagy28, which similarly to MG132 decreased CPE (Fig. 6).
Virus titers, assayed by TCID50 method, confirmed the above data. In fact, from 24 to 48 h p.i., we observed a 
significant decrease of viral production in MG-132 treated groups (Fig. 6).
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Taken together, our data showed that MG-132 reduced virus production.
Discussion
The proteasome system is the major pathway of intracellular protein degradation in eukaryotes. Several studies 
showed that some viruses can use the host ubiquitin-proteasome pathway for their own needs. For example, 
functional proteasomes facilitate HSV-1 entry at a post-penetration stage25. Indeed, proteasome inhibitors impair 
incoming HSV-1 capsid transport to the nuclear periphery but do not affect cell attachment, penetration, or 
membrane fusion25. To date, whether the ubiquitin-proteasome pathway mediated BoHV-1 replication remains 
largely unknown. Thus, the aim of this study was to explore the effect of MG-132, a proteasome inhibitor, on the 
BoHV-1 replication in MDBK cells. Moreover, we analyzed the expression of viral and cellular proteins and their 
role during viral infection.
MG-132 induced a time-dependent decrease in cytotoxicity of infected cells and inhibited BoHV-1-induced 
apoptosis in MDBK cells (Fig. 2). In particular, analysis of apoptotic pathway showed the activation of both exam-
ined caspases and the PARP cleavage (Fig. 3), according to previous studies4,6,8–11. MG-132 completely inhibited 
Figure 2. MG-132 inhibits BoHV-1-induced apoptosis in MDBK cells. (A) Cell lysate was prepared from 
mock-infected cells (lanes C), or infected cells, exposed or not to MG-132 and, for the indicated times, Western 
blot analysis was performed with an antibody which specifically recognized pro-caspase 9, cleaved caspase 9, 
pro-caspase 3, cleaved caspase 3, Bax, Bcl-2, Bcl-XL, PARP, cleaved PARP, p53, p-p53 or β-actin. β-actin was 
used as an internal loading control. Blots are representative of three separate experiments. (B,C) Bax/Bcl-2 
and p-p53/p53 ratio were obtained by densitometry analysis of the relative blots shown in (A). Results are the 
mean ± S.E.M. of three separate experiments.
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Figure 3. MG-132 stimulates autophagy in MDBK cells during BoHV-1 infection. (A) Cell lysate was prepared 
from mock-infected cells (lanes C), or infected cells, exposed or not to MG-132 and, for the indicated times. 
Western blot analysis was performed with an antibody which specifically recognized LC3-I, LC3-II, beclin 1, 
ATG5 or β-actin. Blots are representative of three separate experiments. (B) Densitometry analysis of the LC3-II 
blots shown in (A). (C) Cell lysate was prepared from infected cells, exposed or not to 3-MA and LiCl for 24 h. 
Western blot analysis was for LC3-I, LC3-II or β-actin. Blots are representative of three separate experiments. 
(D) Photomicrographs showing morphology of MDBK cells stained with Giemsa. After 48 of infection, 
compared to the control groups, in MG-132 exposed groups a large number of cells exhibited an increase of 
characteristic signs of autophagy, such as an elevated degree of vacuolization in the cytoplasm (arrow) which 
often indicates an increased autophagic flux (magnification × 150); microphotographs of cells staining with 
acridine orange that revealed the induction of acidic vesicular organelles. Moreover, in infected cells were 
detected both typical necrotic morphology (star) and apoptotic features (arrow). Whereas, we distinguished 
only necrotic features in MG-132 infected cells (star). Detection of green and red fluorescence in acridine 
orange-stained cells was performed using a fluorescence microscope in MDBK control cells, infected and 
treated or not with MG-132 at 48 h p.i., (magnification × 1000); immunofluorescence for LC3 in infected cells 
treated or not with MG132 for 48 h, studied as described in Methods Section (magnification × 400).
www.nature.com/scientificreports/
6Scientific RepoRts | 7: 13306  | DOI:10.1038/s41598-017-13717-1
BoHV-1-induced apoptosis, by blocking the activation of initiator caspase 9, as well as, of executioner caspase 3, 
and no cleavage of PARP was observed (Fig. 3). The levels of pro-apoptotic member Bax increased as a function 
of time after infection, while decreased the levels of anti-apoptotic members such as Bcl-2 and Bcl-XL (Fig. 3)6,8. 
These results were accompanied by a decrease of both pro-apoptotic and anti-apoptotic members. In particu-
lar, we detected that Bax/Bcl-2 ratio was significantly decreased by MG-132 (Fig. 3). Key tumor suppressor p53 
typically contributes to BoHV-1-induced apoptosis6 and Ser315 locates within the nuclear localization signal 
(aminoacids 305-322) of the C-terminal region of p53. Ser315 is phosphorylated by kinases involved in cell cycle 
progression, such as cyclin-dependent kinase cdk932. It has been shown that Ser315 phosphorylation is required 
for the E2F family to enhance p53-mediated transcription and apoptosis33. Thus, we choose to study Ser315 phos-
phorylation and we found that BoHV-1 induced p53 phosphorylation at serine 315 as later as 24 h to the end of 
infection (Fig. 3), suggesting that phosphorylation levels increased with cell death, as we previously detected in 
the same model of cell line34. Indeed, in the absence of MG-132, the infection slightly induced p53 protein levels6. 
Here, both p-p53 and p53 protein levels were decreased by MG-132 (Fig. 2A). Moreover, by measuring the p-p53/
p53 ratio, we detected a significant decrease in MG-132 exposed groups, at all times studied (Fig. 2A-C). Taken 
together, those results confirmed that, in bovine cells infected with BoHV-1, MG-132 did not induce significant 
apoptosis, as in cells infected with HSV-135.
Infection of MDBK cells with the bICP0 null mutant, a BoHV-1 recombinant virus, leads to an accumulation 
of autophagosomes that are not detected following infection with BoHV-17. Herein, we used an inhibitor of auto-
phagy, like 3-MA (Fig. 3)28. Our results provided evidence that a small amount of autophagy takes place during 
BoHV-1 infection in MDBK. It is well established that necrosis is the predominant type of cell death in infected 
cells. Apoptotic cell death only occurs near the end of productive infection in MDBK cells6–8. Following infection 
of MDBK cells, biochemical and morphological results showed that MG-132 induced autophagy (Fig. 3), as well 
as strongly inhibited the activation of bICP0 (Fig. 4). Moreover, MG-132, as LiCl (Fig. 3B), caused a significant 
suppression of viral yields in bovine cells (Fig. 6). It is known that bICP0 acts as an ubiquitin ligases and its 
activating effect was attenuated by MG-13217. Interestingly, bICP0 null mutant, a virus generated by homolo-
gous recombination, stimulates the formation of cytoplasmic vesicles similar to autophagosomes, suggesting that 
bICP0 null mutant induced autophagy in MDBK cells but not in rabbit skin cells7. Intriguingly, MG-132 infected 
cells, stained by acridine orange, appeared with rounded nuclei and elongated fusiform morphology (Fig. 3), 
similar to cultures infected with the bICP0 null mutant36. Moreover, bICP0 null mutant induces low levels of 
apoptosis7 and does not produce plaques by growing weakly in bovine cells36. In fact, it has been demonstrated 
Figure 4. MG-132 inhibits protein expression of bICP0 during infection in MDBK cells. Cell lysate was 
prepared from mock-infected cells (lanes C), or infected cells, exposed or not to MG-132 and, for the indicated 
times, Western blot analysis was performed with an antibody which specifically recognized bICP0 or β-actin. 
β-actin was used as an internal loading control. The molecular weight (in kDa) of protein size standards is 
shown on the left hand side. Blots are representative of three separate experiments.
Figure 5. MG-132 delayed the translocation of NF-κB from cytoplasm to nuclei during infection in MDBK 
cells. Cell lysate was prepared from mock-infected cells (lanes C), or infected cells, exposed or not to MG-
132 and, for the indicated times, Western blot analysis was performed with an antibody which specifically 
recognized NF-κB, β-tubulin or Lamin A/C. β-tubulin and Lamin A/C were used as internal loading controls. 
The molecular weight (in kDa) of protein size standards is shown on the left hand side. Blots are representative 
of three separate experiments.
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that infection of bovine cells with bICP0 null mutant resulted in at least 100-fold lower virus titres, indicating that 
bICP0 protein expression is important, but not required, for virus production36.
Entry of BoHV-1 into cells, such as HSV-1, is a multistep process which involves the host cell machinery. 
Herein, MG-132 was added to cells at the time of infection and, as above reported, it has been known for some 
time that MG-132 treatment inhibits transport of the HSV-1 capsid to the nucleus25. Inhibition of BoHV-1 infec-
tion at such a very early stage (prior to delivery of the genome to the nucleus) is suggested by the complete lack 
of expression of the viral immediate early activator bICP0 at any time point in the presence of MG-132 (Fig. 4). 
BoHV-1 strains null for ICP0 are severely attenuated for lytic replication36 and thus, in the absence of detecta-
ble bICP0 protein, and with no data showing expression of downstream viral genes, it is unclear to what extent 
MG-132 is exerting any of its effects on BoHV-1 replication, as opposed to initial entry. Reduced initial infection 
would also explain reduced cytopathic effect, and reduced final titer (Fig. 6), seen in the presence of MG-132. 
It has been proposed that proteasome-mediated degradation of a virion or host protein is regulated by ICP0 to 
allow efficient delivery of entering HSV-1 capsids to the nuclear periphery37. But, ICP0-deficient virions are not 
blocked by proteasomal inhibitors and enter cells via a proteasome-independent mechanism37. Thus, we hypothe-
size that BoHV-1, like HSV-1, may enter cells in an ubiquitin independent manner, as HSV-1 successfully entered 
cells in the absence of a functional host ubiquitin-activating enzyme25. We also suppose that MG-132 may have 
a reversible inhibitory effect on BoHV-1 entry, such as occurs in HSV-1 infection25. Finally, inactivation of the 
ubiquitin-proteasome pathway inhibits viral replication in a manner that closely follows multiplicity and cell-type 
dependence of the requirement for ICP038, thus to elucidate the role that MG-132 plays with respect to BoHV-1 
infection, it will be necessary to realize further studies.
Signaling events leading to NF-κB activation constitute a major antiviral immune pathway. Particularly, acti-
vation of NF-κB transcription pathway is crucial for the immediate early step of immune activation. To replicate 
and persist within their hosts, viruses have evolved different strategies to evade cellular NF-κB immune signaling 
cascades for their benefit16. BoHV-1 shares certain biological properties with HSV-11,2. And in HSV-1 cellu-
lar proteasome activity inhibitors prevent virus induced NF-κB activation in the early phase of infection and 
decreases immediate early as well as late protein expressions, and suppresses viral replication18. Our results sug-
gest that, in the presence of MG-132, the inhibition of bICP0 could significantly delayed the activation of NF-κB 
(Fig. 5).
Interestingly, MG-132 impaired the entry of Japanese encephalitis virus (JEV) and its initial translation. The 
internalized JEV viral particles were misdirected to the lysosomes, resulting in non-productive entry39. This paper 
proposed a dramatically different role for MG-132 than those proposed by other authors and here. But JEV is 
a positive-stranded enveloped RNA virus that belongs to the family Flaviviridae whereas, it has been reported 
that double-stranded-DNA-mediated NF-κB activation is critical for host antiviral responses. Indeed, the HSV-1 
ubiquitin-specific protease (UL36USP), which is a deubiquitinase (DUB), antagonizes NF-κB activation, depend-
ing on its DUB activity40. The N terminus of the HSV-1 UL36 gene-encoded protein contains the DUB domain 
and is conserved across all herpesviruses. UL36USP abrogates NF-κB activation by cleaving polyubiquitin chains 
from IκBα and therefore restricts proteasome-dependent degradation of IκBα and DUB activity is indispensable 
for this process40.
An important virulence mechanism of HSV-1 is the control of autophagy. In fact, HSV-1 inhibits autophagic 
responses through binding of the viral protein ICP34.5 to the host protein Beclin141. Recently, Yakoub and Shukla 
argued that MG-132 stimulates autophagy in HSV-1 infection and suppresses infection in various cell types35 
Figure 6. MG-132 reduces virus production during productive infection in MDBK cells. (A) Representative 
microphotographs by phase-contrast light microscopy of MDBK control cells, untreated or treated with MG-
132, infected with BoHV-1 and untreated or treated with MG-132 and LiCl at 48 h p.i., showing the cytopathic 
effects and the morphological changes on cellular monolayers. (B) Virus titers, assayed by TCID50 method and 
reported as Log TCID50/ml.
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(2015). Emerging evidence suggests that during infection, autophagy may act as an antiviral mechanism, by 
decreasing the replication, or enhancing the degradation of many viruses42. Our findings indicate that the efficient 
virus release provoked by BoHV-1 may be lowered by proteasome inhibitor (See Diagram in Fig. 7). Furthermore, 
in BoHV-1 infection MG-132 might stimulate autophagy, a highly conserved cellular degradative pathway, and 
significantly limit infection in bovine cells, without affecting cell viability, according to the theory that autophagy 
induction may prevent cell death. Indeed, autophagic activity of a cell was shown to be inversely proportional to 
the probability of its death43,44.
In many European countries BoHV-1 is widespread and IBR eradication still represents a goal45–47, as the 
virus is responsible for significant losses incurred by disease and trading restriction in the cattle industry2. Thus, 
we suppose that the activation of autophagy may provide an antiviral defense mechanism in infections caused by 
the BoHV-1.
Methods
Cell cultures and virus infection. MDBK cells (American Type Culture Collection, CCL22) were cultured 
in Dulbecco’s modified Eagle’s minimal essential medium (DMEM), supplemented with 2% foetal calf serum 
(FCS), 1% L-glutamine, 1% penicillin/streptomycin, 0.2% sodium pyruvate and 0.1% tylosin, a macrolide-class 
antibiotic. Cells were maintained in an incubator at 37 °C (in 5% CO2/95% air). This cell line was maintained free 
of mycoplasma and of bovine viral diarrhoea virus as described9. The BoHV-1 Cooper strain was used through-
out the study. Virus stocks were routinely grown on MDBK cells and were also used for determination of virus 
titers26,27. Proteasome inhibitor carbobenzoxy-L-leucyl-L-leucyl-L-leucinal (MG-132) (Calbiochem, 474790) was 
dissolved in dimethyl sulfoxide and added to the media to a final concentration of 1 μM. In addition, we used both 
an inducer and an inhibitor of autophagy, 10 mM lithium chloride (LiCl) and 10 mM 3-methyladenine (3-MA), 
respectively (all from Sigma-Aldrich). All other chemicals were of the highest commercially available purity.
MDBK cells, at confluency, were washed with DMEM and then infected or not with BoHV-1, at multiplicity of 
infection (MOI) of 5, at the same time, in the presence or absence of MG-132. After 1 hour of adsorption at 37 °C, 
the cells were incubated for indicated times post infection (p.i.) and then processed. The virus was present in the 
culture media throughout the course of the experiment.
Cell viability. Cell viability was assessed by Trypan blue (TB) exclusion test, as we described4,8. Briefly, cells 
were collected by trypsinization, at the indicated times after infection, and an aliquot of the cell suspension was 
mixed with an equal volume of 0.2% Trypan-blue (Sigma) in 1 × phosphate-buffered saline (PBS). After 10 min, 
cells were counted using a Burker chamber under a phase contrast microscope. Cell viability was calculated as 
percentage of live cells over the total cells number, and results are the mean ± S.E.M. of four independent exper-
iments performed in duplicate.
Examination of cell morphology. Cell morphology was examined by light microscopy following Giemsa 
staining34. Briefly, monolayers of MDBK cells (105 cells per well), in 16-well culture chambers, were infected or 
not with BoHV-1, at MOI of 5, in the presence or absence of MG-132, and incubated at 37 °C. After 4, 24 and 
48 h p.i., cells were washed twice with PBS. Cells were fixed with 95% ethanol, drained and dried. Afterward, cells 
were stained with a 5% Giemsa solution (Merck, 109203). After 30 min cells were rinsed with tap water and H20. 
The slides were mounted in Entellan (Merck, 100869) and coverslipped. Light microscopic studies and photo-
micrographs observations were carried out. Non-apoptotic cell death was identified by the criteria previously 
described30,48,49.
Figure 7. Schematic diagram illustrating the hypothesized mechanisms as to how MG-132 exerts its effects on 
the BoHV-1 replication, resulting in stimulated autophagy and decreased virus replication in MDBK cells.
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Moreover, we detected acidic vesicular organelles (AVOs) with acridine orange as previously described34,50. 
Autophagy is the process of sequestrating cytoplasmic proteins into the lytic component and it is characterized by 
the formation and promotion of AVOs. In order to detect the AVO in cells, we carried out the vital staining with 
acridine orange. In acridine orange-stained cells, the cytoplasm and nucleolus fluoresce bright green and dim 
red, whereas acidic compartments fluoresce bright red51,52. The intensity of the red fluorescence is proportional 
to the degree of acidity of the cellular acidic compartment. Monolayers of MDBK cells grown on glass coverslip, 
at confluency, were washed with DMEM and were infected or not with BoHV-1, at MOI of 5, in the presence or 
absence of MG-132, and incubated at 37 °C. After 4, 24 and 48 h p.i., cells were washed with PBS and stained with 
acridine orange (Sigma, A6014) at a final concentration of 1 μg/ml for 15 minutes. Stained cells were placed on a 
microscope slide and observed under UV with a fluorescence microscope (Nikon).
Immunofluorescence and confocal analysis. Monolayers of MDBK cells grown on glass coverslip, at 
confluency, were washed with DMEM and were infected or not with BoHV-1, at MOI of 5, in the presence or 
absence of MG-132, and incubated at 37 °C. At 4, 24 and 48 h p.i., cells were washed with PBS and then fixed 
with paraformaldehyde (4% w:v). After rinsing in PBS, the cells were permeabilized with 0.1% Triton X-100 in 
PBS for 1 min and blocked in 4% BSA in PBS for 30 min. This was followed by incubation in rabbit polyclonal 
microtubule-associated protein light chain 3 (LC3) antibody (1:200) (Novus Biologicals, NB100-2220), for 24 h 
at 4 °C in a humidified chamber. After 3 washes in PBS, the cells were incubated in anti-rabbit IgG conjiugated to 
Cy3 (1:150) (Sigma, C2306) for 1 h at room temperature. Then, cells were rinsed in PBS, coverslipped and exam-
ined with a confocal microscope (Zeiss).
Isolation of nuclear and cytosolic fractions. Isolation of nuclear and cytosolic fractions was carried out 
as previously described4. MDBK cells were harvested and washed twice with ice cold PBS, then centrifuged at 
1,200 rpm for 7 min at 4 °C. Pellets were re-suspended in 0.33 M sucrose, 10 mM Hepes (pH 7.4), 1 mM MgCl2, 
0.1% Triton X-100 in 5:1 v/v (ice cold and in the presence of protease inhibitors). After 15 min on ice, aggre-
gates were broken up gently with thin glass rod and centrifuged at 3,000 rpm for 5 min at 4 °C. The supernatants 
representing the cytosolic fractions and the pellets containing a pure preparation of nuclei without the nuclear 
membrane were obtained and stored at −70 °C. Nuclear pellets were gently re-suspended in ice cold 0.45 M NaCl, 
10 mM Hepes pH 7.4 (in the presence of protease inhibitors). The suspension was incubated on ice for 15 min. 
After centrifugation at 14,000 rpm for 5 min at 4 °C, supernatant representing the nuclear extract was collected 
and then Western blot analysis of nuclear and cytosolic fractions were performed to detect NF-κB.
Protein extraction and Western blot analysis. Protein extraction and Western blot analysis were car-
ried out as we previously described4,8,9,34. The following antibodies, dissolved in 5% bovine serum albumin-TBST, 
were used: anti-caspase-3 PAb (1:1000) (Santa Cruz Biotechnology, sc-1225), anti-caspase-9 PAb (1:500) (Acris 
Antibodies, Inc., AP00004PU-N), anti-p53 MAb (1:1000) (Santa Cruz Biotechnology, sc-99), anti-phospho-p53 
PAb (Ser315) (1:1000) (Cell Signaling, 2528), anti-PARP Mab (1:5000) (Biomol, BML-SA250-0050), anti-Bax Pab 
(1:1000) (Abcam, ab7977), anti-Bcl-2 Pab (1:1000) (Abcam, ab7973), anti-Bcl-XL Pab (1:1000) (Abcam, ab2568), 
polyclonal rabbit anti-bICP0 (a.a. 663–676) serum (1:800), kindly provided by Prof. M. Schwyzer (University of 
Zurich, Switzerland)3, anti-LC3 PAb (Novus Biologicals, NB100-2220) (1:1500), anti-ATG-5 (Novus Biologicals, 
NB110-53818) (1:500), anti-Beclin 1 PAb (Novus Biologicals, NBP1-00088) (1:1000), anti-NF-κB Mab (1:1500) 
(Imgenex, IMG150B), antin-Lamin A/C MAb (Sigma, SAB4200236), anti-β-tubulin PAb (Abcam, ab6046) and 
anti-β-actin MAb (Sigma, A5316) (1:7500). The images of Western immunoblot specific bands on X-ray films 
were imported into a computer by a scanner and captured as digital TIFF images. The results were plotted in a 
graph after densitometry analysis of the obtained blots. Moreover, both Bax/Bcl-2 and p-p53/p53 ratio in infected 
groups, in the presence or in absence of MG-132, were obtained by densitometric evaluation.
Virus production. MDBK cells, at confluence, were infected with BoHV-1 at MOI 5, in the presence or not 
of MG-132 and LiCl, as above reported. For the virus production assay, we analyzed both viral cytopathic effects 
(CPE) and virus titration. At 24 or 48 h p.i., all groups were observed under light microscope to evaluate CPE, 
represented by ample syncytia formation along with elimination of the cellular sheets. For virus titration, at 4, 24 
or 48 h p.i., cell extracts, obtained by three cycles of freezing and thawing, were collected and stored in aliquots 
at −80 °C. Virus titers were assayed by TCID50 method according to Reed and Muench (1938)53, as previously 
described26,27.
Statistical analysis. Data are presented as mean ± S.E.M. One-way ANOVA with Tukey’s post-test was per-
formed using GraphPad InStat Version 3.00 for Windows 95 (GraphPad Software, San Diego, CA). P value < 0.05 
was considered statistically significant.
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